If your failure to meet CGMP results in the distribution of the drug that doesn't provide the benefit as labeled since, as an example, it has also little active ingredient, the company may possibly subsequently recall that product.For many API producers, the plants they depend on in China are their own. Lonza as well as Swiss company Siegfried are … Read More